Lannett Confident Of $1bn In Sales By 2025

Lantus And Advair Among Key Projects

 
• By Dean Rudge
  
US-Money-and-Pills_V2_1200x675
Complex dosage forms via partnerships are driving Lannett towards growth in the future • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business